The increased levels of AEA and 2-arachidonoylglycerol (2-AG), another arachidonic acid-derived endocannabinoid, have led to the concept of the 'overactivated' endocannabinoid system in obesity in which FAAH expression is reduced [6,7,17]. This evidence concerns the gene FAAH and obesity disorder.